Genepredit

Ousia Pharma

This biotechnology company develops peptide-drug conjugates to treat obesity and cardiometabolic diseases for patients requiring improved metabolic health and weight regulation.

Carmot Therapeutics

This biotechnology company develops drug therapies to treat metabolic diseases, such as obesity and diabetes, for patients with these conditions.

Develogen

The company develops therapeutics for metabolic and endocrine disorders to assist pharmaceutical partners in treating conditions such as diabetes and obesity.

AdipoPharma SAS

This biotech company develops a therapeutic peptide to treat insulin resistance and type 2 diabetes for patients with metabolic diseases.

eracal

This biotechnology company develops anti-obesity medicines and appetite modulators for patients with metabolic disorders.

AdipoPharma

This clinical-stage biotechnology company develops therapeutic peptides to treat insulin resistance and type 2 diabetes for patients with metabolic disorders.

Resalis Therapeutics

This company develops non-coding RNA therapies to treat metabolic disorders, including obesity and fatty liver disease, for patients with unmet medical needs.

Moonwalk Therapeutics

This biotechnology company develops epigenetic and RNA interference medicines to treat obesity and cardiometabolic diseases for patients.